Rafi Mohammad, PhD

Rafi Mohammad, PhD, is a pharmaceutical development professional currently serving as an Associate Director at Bayer, based in Berkeley, California. He has over ten years of experience in the pharmaceutical industry, specifically focusing on drug formulation and development for biologics, including cell and gene therapies.

Professional Background

• Current Position: Associate Director at Bayer since May 2021, where he leads the formulation and process development for cell and gene therapies. He has also taken on the role of Senior Director (Interim) since February 2023, overseeing formulation and drug product development for biologics, including cell therapies and antibodies.13

• Previous Experience: Rafi has held various roles at Bayer, including Staff Scientist and Scientist, where he was involved in late-stage formulation and drug product development for clinical studies, particularly in oncology and hemophilia. His work has included technology transfer, regulatory submissions, and project management.12

• Academic Background: Rafi earned his PhD in Internal Medicine from the University of Tokyo, Japan, where he conducted research on pharmacological activities of anticancer drug-loaded nanomedicines. He also holds a Master's degree in Biotechnology and a Bachelor's degree in Pharmaceutical Sciences from Jawaharlal Nehru Technological University in India.12

Contributions and Skills

Rafi's expertise lies in the development of biologics and drug compatibility assessments for clinical trials. He has a strong background in nanomedicine and has contributed to the development of targeted therapies for various diseases. His skills include drug formulation, process development, and project management in a pharmaceutical context.13

In addition to his technical skills, Rafi has been involved in professional development initiatives, serving on committees for young scientists and organizing events to foster community engagement within the scientific field.1